Osteoporosis medications assessed by the study investigators included several bisphosphonates (for example, alendronate, clodronate and etidronate); raloxifene; strontium ranelate; and parathyroid ...
Another problem is the issue of fertility and reproduction. Osteoporosis requires long-term use of drugs that have not been tested on pregnant women, and their influence on fetus growth and ...
He explained, “Traditional approaches to osteoporosis treatment involve medications to slow bone ... of the purposes explained in this notice. List of IAB Vendors Actively scan device ...
July 24, 2024 — Surgeons compared traditional and new fully hydroxyapatite-coated hip replacement stems. They found the new stems offer larger contact areas, while traditional ones preserve bone ...
Osteoporosis is more common in women than men, and is usually related to hormonal changes after the time of menopause. While osteoporosis is generally regarded as a natural part of the ageing ...
According to Indian Menopause Society, around 50 million women in India are affected by osteoporosis, with the risk significantly increasing post-menopause. The menopausal syndrome often manifests ...
Nonadherence to pharmacological treatment in osteoporosis is a well-recognized problem. As in other chronic diseases, adherence to osteoporosis treatment is poor, resulting in enormous burden on ...
The Business Research Company's Osteoporosis Drugs Global Market Report 2024 – Market Size, Trends, And Market Forecast 2024-2033 You Can Now Pre Order Your Report To Get A Swift Deliver With ...
The leading medication used to treat osteoporosis in Australia, making up more than 70 per cent of market share It's administered by injection every six months, and can't be late or skipped It ...
Most conventional anti-osteoporosis medications are contraindicated in CKD patients because they may worsen renal function. Therefore, there was urgent need to develop safe and effective drugs for ...